Ethnicity Disparities in the Prevalence, Awareness, Treatment, and Control Rates of Hypertension in China

Yang, Yanan; He, Kunlin; Zhang, Yuewen; Wu, Xiuming; Chen, Weizhong; Gu, Dongqing; Zeng, Ziqian

doi:https://doi.org/10.1155/2023/1432727

International Journal of Hypertension

On this page

Abstract Introduction Methods Results Discussion Conclusions Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2023 | Article ID 1432727 | https://doi.org/10.1155/2023/1432727

Ethnicity Disparities in the Prevalence, Awareness, Treatment, and Control Rates of Hypertension in China

Yanan Yang,¹Kunlin He,²Yuewen Zhang,¹Xiuming Wu,¹Weizhong Chen,¹Dongqing Gu,³and Ziqian Zeng¹

Academic Editor: Kai Hu

Received28 Jun 2022

Revised23 Dec 2022

Accepted01 Mar 2023

Published14 Mar 2023

Abstract

Objectives. Previous studies reported that there were disparities in hypertension management among different ethnic groups, and this study aimed to systematically determine the prevalence, awareness, treatment, and control rates of hypertension in multiple Chinese ethnic groups. Methods. We searched Embase, PubMed, and Web of Science for articles up to 25 October, 2022. The pooled prevalence, awareness, treatment, and control rates of hypertension were estimated with 95% confidence intervals (CI). The heterogeneity of estimates among studies was assessed by the Cochran Q test and I² statistic. Meta-regression analyses were conducted to identify the factors influencing the heterogeneity of the pooled prevalence, awareness, treatment, and control rate of hypertension. Results. In total, 45 publications including 193,788 cases and 587,826 subjects were eligible for the analyses. The lowest prevalence was found in the Han group (27.0%), and the highest prevalence was in the Mongolian population (39.8%). The awareness rates ranged from 24.4% to 58.0% in the four ethnic groups. Both the highest treatment and control rates were found in the Mongolian population (50.6% and 16.0%, respectively), whereas the Yi group had the lowest control rate (8.0%). In addition, the study year, the mean age of subjects, mean body mass index of subjects, tobacco use (%), alcohol use (%), residence (urban%), and education (primary school%) had varied effects on heterogeneity. Conclusions. These findings highlight the disparities in prevalence, awareness, treatment, and control rates of hypertension in a different ethnic population of China, which could provide suggestions for making targeted prevention measures.

1. Introduction

Hypertension is an important risk factor for cardiovascular diseases and other chronic diseases which impose a huge burden on economic and human development globally [1, 2]. Nevertheless, low awareness, treatment, and control of hypertension will handle the prevention progress of cardiovascular diseases [3–5]. In China, the median prevalence of hypertension was 32% in females and 37% in males [6], which were higher than the average level of 20% of women and 24% of men around the world [1]. The awareness, treatment, and control rates reported by a systematic review were only 53%, 44%, and 17%, respectively, among the female population, and these rates were even lower in men [6].

Some studies reported that the prevalence rate of hypertension may be different in each ethnic group, which could be attributed to the different genetic and environmental conditions [7–10]. China is a unified, multinational country, with 56 ethnic groups in all. It is evident that the status and management of hypertension are varied in these groups [11]. Understanding the status of the ethnic groups was beneficial for hypertension control.

Most of the individual studies were conducted for one ethnic group, however, systematically collected data to compare the prevalence, awareness, treatment, and control rates among varied ethnic populations were insufficient. Therefore, this study investigated the disparities in the management of hypertension among ethnic groups to improve hypertension prevention in order to achieve the global noncommunicable disease targets.

2. Methods

2.1. Data Sources

We searched the three databases (Embase, PubMed, and Web of Science) up to 25 October, 2022. The medical subject heading (MeSH) terms were used for the search strategies. The search strategy was as follows: (blood pressure OR hypertension) AND (epidemiology OR prevalence OR incidence OR awareness OR treatment OR control) AND (China). To maximize the yield of articles, we further screened the references of all included studies or meta-analyses in the database to select additional eligible articles.

2.2. Inclusion and Exclusion Criteria

The eligible articles were under the following criteria: (1) articles that were published in peer-review journals in both English and Chinese; (2) articles that defined hypertension as SBP ≥ 140 mmHg or/and DBP ≥ 90 mmHg; or self-reported pharmacological treatment for hypertension; (3) articles that reported the prevalence or awareness or treatment or control rate; (4) articles that provided the cases and sample size or sufficient data to calculate these rates. Some exclusion criteria were set before data extraction: (1) articles that provided limited information; (2) articles that were not the original research articles, such as review, comment, or letter; (3) articles that focused on the treatment or medication of hypertension. Two investigators (G.DQ and Z.ZQ) evaluated each study and checked the eligibility independently.

2.3. Data Extraction

Data were extracted by two researchers (Y.YN and Z.ZQ) using the standard information forms, including first author name, publishing year, study year, study design type, ethnicity, case number, sample size, prevalence rate, awareness rate, treatment rate, control rate, mean age of the population, age range of population, mean body mass index (BMI), tobacco use (%), alcohol use (%), gender (female%), residence (residence%), and education (education%). When the data from the same survey were published in more than one publication, we used the largest one.

2.4. Quality Assessment

The quality of included studies was independently assessed by two investigators (H. KL and Y. YN) using the adapted Newcastle-Ottawa Scale (NOS) [12]. If there were any disagreements, it was resolved by consultation with another author (G. DQ). Nine items were applied to assess the included studies, and each study received a total score (TS) for methodological quality. The score ranged from 0–10: TS ≥ 7 ranks as “high quality,” 7<TS ≤ 6 ranks as “moderate quality,” and TS < 6 ranks as “low quality.”

2.5. Statistical Analysis

A pooled prevalence, awareness, treatment, and control rates of hypertension were estimated with 95% confidence intervals (CI). The heterogeneity of estimates among studies was assessed by the Cochran Q test and I² statistic. Meta-regression analyses were conducted to identify the factors influencing the heterogeneity. In regression models, the study year (<2010, ≥2010), mean age (years), mean BMI, tobacco use (%), alcohol use (%), gender (female%), residence(urban%), and education (primary school%) were included as covariates. The sensitivity analysis was also conducted to explore the potential heterogeneity. The Egger test and Begg test were performed for publication bias. Statistical analyses were conducted using Stata 14 software (https://www.stata.com/) was defined as statistical significance.

3. Results

3.1. Characteristics of Included Studies

A PRISMA flowchart was used to illustrate the selection of studies (Figure 1) [13]. We screened a total of 3,618 articles, and finally, 45 publications of 193,788 cases and 587,826 subjects were included in the analyses. According to the number of datasets, a total of four ethnic groups (Han, Tibetan, Yi, and Mongolian) were considered to conduct the meta-analyses. There were 14 datasets used for the Han population, 23 datasets used for the Tibetan population, 7 datasets used for the Yi population, and 10 datasets used for the Mongolian population. There were nine datasets conducted in 1996–2005, 37 datasets investigated in 2006–2015, eight datasets conducted in 2016–2019, and one dataset conducted in 1979. More characteristics of included studies were displayed in Supplementary Table 1.

3.2. Quality of the Studies

The quality of included studies was relatively high. According to the results of the quality assessment, 31 (68.9%) studies were categorized as “high quality” and 14 (31.1%) studies were classified as “moderate quality.” The details of the quality assessment are shown in Supplementary Table 2.

3.3. Prevalence, Awareness, Treatment, and Control of Hypertension

All prevalence rates were calculated using the cut-off value (140/90 mmHg), and the awareness, treatment, and control rates were calculated among cases with hypertension. The pooled prevalence, awareness, treatment, and control rates of the total population were 31.7%, 42.5%, 33.4%, and 12.2%, respectively. The lowest prevalence rate was found in the Han group (27.0%), and the highest prevalence was in the Mongolian population (39.8%). The awareness rates ranged from 24.4% to 58.0%% in four ethnic groups. The highest treatment and control rates were found in the Mongolian population (50.6% and 16.0%, respectively). The Yi group had the lowest control rate (8.0%), see Table 1.

3.4. Results from Meta-Regression Analyses

The meta-regression analyses were conducted for the four ethnic groups, respectively. In the meta-regression model for the Han group, the results of mean age and mean BMI were statistically significant, explaining 40.96% () and 35.16% () of the heterogeneity in prevalence between studies, respectively. The mean BMI, alcohol use, and study year explained 54.21% (), 66.83% (), and 54.20% () of the heterogeneity in awareness between studies, respectively. And the mean BMI, alcohol use, study year, and tobacco use were statistically significant, explaining 48.44% (), 53.19% (), 40.19% (), and 26.99% () of the heterogeneity in treatment or control between studies (See Table 2). In the meta-regression model for the Mongolian group, the source of heterogeneity for prevalence was mean age (Adj. R² = 69.12%, ), and education (Adj. R² = 46.36%, ) for control rate (see Table 3). In addition, the residence (Adj. R² = 100.00%, ) affected the awareness rate of the Tibetan group (see Supplementary Table 3). The mean BMI (Adj. R² = 76.68%, ) and study year (Adj. R² = 57.40%, ) also had effects on the prevalence of the Yi group, respectively (see Supplementary Table 4).

3.5. Bias and Sensitivity Analysis

31 (68.9%) studies were judged to be of high quality with a low risk of bias, while 14 (31.1%) studies were at moderate risk of bias. In the sensitivity analyses, no individual study was found to have any major impact on the pooled prevalence, awareness, treatment, and control rate of hypertension (see supplementary Figures 1–4). The Egger test was not statistically significant for testing the publication bias, except in analyses of pooled awareness of the Han population () and the pooled treatment of the Tibetan population (). The Begg test showed no small-study bias in these meta-analyses, all the values were greater than 0.05.

4. Discussion

To our knowledge, this study is the first to systematically summarize the rates of hypertension management in multiple Chinese ethnic groups. In this study, we finally selected four main ethnic groups (Han, Tibetan, Yi, and Mongolian) in our analyses according to the number of databases. Our results indicated that the status varied in these four groups, in which Mongolian had the highest prevalence, treatment, and control rates. However, Yi people had a different story of increasing the prevalence rate and relatively lower the control rate. The results denoted that understanding the differences in varied ethnic groups could inform targeted prevention measures to improve hypertension management and reduce the disparities.

Based on previous findings, the prevalence rates of hypertension would vary in different ethnic populations due to genetic and environmental factors [14, 15]. In our study, the combined prevalence among four ethnic groups was 31.7%, which was slightly higher than the results from the Chinese Hypertension Survey in 2012–2015 which found that the average rate of the Chinese population was 27.9% [16]. In these ethnic groups, the rate of Han nationality was the lowest (27.0%), while the rates of Mongolian and Tibetan were more than 30%. These results were consistent with previous studies [17]. Most of the Tibetan population in China are living in the highlands, and some publications indicated that chronic hypoxia exposure may cause a higher prevalence of hypertension [18]. In addition, according to our previous studies, hypoxia exposure may also increase the risk of other diseases, such as sleep disorders, which were regarded as the risk factors for hypertension [19, 20]. For the Mongolian population, the prevalence was high in the recent thirty years in some large-scale surveys [21]. This phenomenon may be attributable to the changes in their diet culture because Mongolian people prefer to consume meat and milk as the principal food, especially among people living in pastoral regions [22]. Yi population was found to have a low prevalence of both overweight and obesity [23], which may contribute to a lower rate of hypertension (28%). However, the population attribution fraction (PAF) of overweight or obesity in this population was also increasing in recent years. For example, in 1996, the PAF was 27.66% and the rate of hypertension was 5.33% in 1996, while the PAF increased to 33.26% in 2015 with a prevalence of hypertension of 17.2% [24].

Furthermore, among people with hypertension, the awareness, treatment, and control rates were also analyzed in this study. In China, the average rates were 51.5%, 46.1%, and 16.9% reported by a nationwide survey in 2015 [25], which were higher than the rates reported in other developing countries, such as Ghana [26]. In this study, only the rates from the Mongolian population were close to this level, and the Tibetan and Han population slightly lower than that level, while these rates in the Yi group were the lowest. Two possible reasons might account for these results. Firstly, compared to the other groups, Yi people had a relatively lower prevalence of hypertension over a long-term period, which may make them pay less attention to the increase of risk factors at the population level. For example, some studies had reported that Yi people’s dietary patterns changed largely in the past two decades, which caused the gradual growth of the prevalence of hypertension [27, 28]. Secondly, the previous studies showed that numerous Yi people migrated from rural to urban areas, which imposed heavy pressure on the prevention of these two distinct groups. Yi migrants usually had a higher prevalence of hypertension than Yi farmers, and it was useless to implement the same measures to improve their awareness, treatment, and control situation among Yi people. More targeted strategies and policies are needed in the Yi population.

There are some strengths in our study. The pooled estimates of the prevalence, awareness, treatment, and control of hypertension in four main Chinese ethnic groups were reported comprehensively. The search strategy involved plenty of studies and subjects based on the standard of PRISMA [29]. Our results were robust and corroborated by further sensitivity analyses and the tests of small-study bias and publication bias. Nonetheless, there are also some limitations. Firstly, high heterogeneity was found in our meta-analyses, which were familiar with other meta-analytic studies focusing on the pooled rates because of the differences in the study population, inclusion and exclusion criteria, and assessment [30, 31]. In this systematic review, we also included some common covariates to explore the source of heterogeneity, such as BMI, gender, tobacco use, alcohol use, age, study year, and education. Of which, mean age, mean BMI, study year, alcohol use, and tobacco use were significantly associated with the rates of hypertension management. Secondly, some other Chinese ethnic groups, such as Zhuang, Uygur, and Hui, were not included in the meta-analyses because of insufficient datasets.

5. Conclusions

The systematic review included four main Chinese ethnic groups and conducted meta-analyses for prevalence, awareness, treatment, and control rates of hypertension. The findings suggest that hypertension management varied in these Chinese ethnic groups which Mongolian and Tibetan had higher prevalence rates. Notably, the Yi population was regarded as the low-risk population for hypertension, and it should pay more attention to prevention because the prevalence rates were rising in recent years, while their awareness, treatment, and control rates were still low. We call for further studies to better understand the specific risk factors and mechanisms of hypertension in the Tibetan and Mongolian populations to make more targeted preventive measures. In addition, for Yi people, it is urgent to implement interventions to improve their awareness and treatment, and finally achieve the goal of hypertension control.

Data Availability

The data used to support the findings of this research are available from major databases, including Embase, PubMed, and Web of Science.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Y.YN and H.KL contributed equally. They extracted the data, performed the analysis, and wrote the first draft. Z.YW, W.XM, and C.WZ were involved in the data analysis. Z.ZQ conducted the research and revised the draft. G.DQ and Z.ZQ contributed equally and supervised the data extraction and interpretation of the statistics.

Acknowledgments

The authors gratefully acknowledge all research assistants for their contribution to this study. This work was supported by the Collaborative Fund from Chengdu Medical College-Yibin Center for Disease Control and Prevention (grant number: 2021LHYB04).

Supplementary Materials

Supplementary Table 1: the characteristics of included studies. Supplementary Table 2: the quality of references assessed by the adjusted Newcastle Ottawa Assessment Scale. Supplementary Table 3: meta-regression analysis of the Tibetan group to explore potential sources of heterogeneity, prevalence, awareness, treatment, and control. Supplementary Table 4: meta-regression analysis of the Yi group to explore potential sources of heterogeneity and prevalence. Supplementary Figure 1: the sensitivity analyses of data from Han population, 1A prevalence of Han, 1B awareness of Han, 1C treatment of Han, and 1D control of Han. Supplementary Figure 2: the sensitivity analyses of data from Tibetan population, 2A prevalence of Tibetan, 2B awareness of Tibetan, 2C treatment of Tibetan, and 2D control of Tibetan. Supplementary Figure 3: the sensitivity analyses of data from Yi population, 3A prevalence of Yi, 3B awareness of Y, 3C treatment of Y, and 3D Control of Yi. Supplementary Figure 4: the sensitivity analyses of data from Mongolian population, 4A prevalence of Mongolian, 4B awareness of Mongolian, 4C treatment of Mongolian and 4D control of Mongolian. (Supplementary Materials)

References

NCD Risk Factor Collaboration NCD-RisC, “Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants,” Lancet, vol. 389, no. 10064, pp. 37–55, 2017.
View at: Publisher Site | Google Scholar
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration, “Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment,” Lancet Diabetes & Endocrinology, vol. 2, no. 8, pp. 634–647, 2014.
View at: Publisher Site | Google Scholar
R. R. Dhungana, A. R. Pandey, and N. Shrestha, “Trends in the prevalence, awareness, treatment, and control of hypertension in Nepal between 2000 and 2025: a systematic review and meta-analysis,” International Journal of Hypertension, vol. 2021, Article ID 6610649, 8 pages, 2021.
View at: Publisher Site | Google Scholar
B. Kuate Defo, J. C. Mbanya, J. C. Tardif et al., “Diagnosis, prevalence, awareness, treatment, prevention, and control of hypertension in Cameroon: protocol for a systematic review and meta-analysis of clinic-based and community-based studies,” JMIR Res Protoc, vol. 6, no. 5, p. e102, 2017.
View at: Publisher Site | Google Scholar
N. Mohammadian Khonsari, E. Shahrestanaki, H. S. Ejtahed et al., “Long-term trends in hypertension prevalence, awareness, treatment, and control rate in the Middle East and north africa: a systematic review and meta-analysis of 178 population-based studies,” Current Hypertension Reports, vol. 23, no. 9, p. 41, 2021.
View at: Publisher Site | Google Scholar
A. Redfern, S. A. E. Peters, R. Luo et al., “Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses,” Hypertension Research, vol. 42, no. 2, pp. 273–283, 2019.
View at: Publisher Site | Google Scholar
R. Miranda, K. A. C. Meeks, M. B. Snijder et al., “Health literacy and hypertension outcomes in a multi-ethnic population: the HELIUS study,” The European Journal of Public Health, vol. 30, no. 3, pp. 516–521, 2020.
View at: Publisher Site | Google Scholar
L. K. Hill and J. F. Thayer, “The autonomic nervous system and hypertension: ethnic differences and psychosocial factors,” Current Cardiology Reports, vol. 21, no. 3, p. 15, 2019.
View at: Publisher Site | Google Scholar
G. C. Chan, B. W. Teo, J. C. Tay et al., “Hypertension in a multi-ethnic Asian population of Singapore,” Journal of Clinical Hypertension, vol. 23, no. 3, pp. 522–528, 2021.
View at: Publisher Site | Google Scholar
E. L. van der Linden, B. N. Couwenhoven, E. J. A. J. Beune, J. G. Daams, B. J. H. van den Born, and C. Agyemang, “Hypertension awareness, treatment and control among ethnic minority populations in Europe: a systematic review and meta-analysis,” Journal of Hypertension, vol. 39, no. 2, pp. 202–213, 2021.
View at: Publisher Site | Google Scholar
M. Heizhati, L. Wang, X. Yao et al., “Prevalence, awareness, treatment and control of hypertension in various ethnic groups (Hui, Kazakh, Kyrgyz, Mongolian, Tajik) in Xinjiang, Northwest China,” Blood Pressure, vol. 29, no. 5, pp. 276–284, 2020.
View at: Publisher Site | Google Scholar
G. Wells, B. Shea, D. O’connell et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses, Oxford University Press, Oxford, UK, 2000.
D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009.
View at: Publisher Site | Google Scholar
J. Dubroff, L. Melendres, Y. Lin, D. R. Beene, and L. Ketai, “High geographic prevalence of pulmonary artery hypertension: associations with ethnicity, drug use, and altitude,” Pulmonary Circulation, vol. 10, no. 1, pp. 1–10, 2020.
View at: Publisher Site | Google Scholar
F. Liu, D. Adi, X. Xie et al., “Prevalence of isolated diastolic hypertension and associated risk factors among different ethnicity groups in xinjiang, China,” PLoS One, vol. 10, no. 12, Article ID e0145325, 2015.
View at: Publisher Site | Google Scholar
Joint Committee for Guideline Revision, “Chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of Chinese guidelines for prevention and treatment of hypertension,” Journal of Geriatric Cardiology, vol. 16, no. 3, pp. 182–241, 2019.
View at: Publisher Site | Google Scholar
P. Yu, Y. Ning, Y. Gao et al., “Hypertension among Mongolian adults in China: a cross-sectional study of prevalence, awareness, treatment, control, and related factors: hypertension among Mongolian adults in China,” Journal of Clinical Hypertension, vol. 23, no. 9, pp. 1786–1801, 2021.
View at: Publisher Site | Google Scholar
J. Brito, P. Siques, and E. Pena, “Long-term chronic intermittent hypoxia: a particular form of chronic high-altitude pulmonary hypertension,” Pulmonary Circulation, vol. 10, no. S1, pp. 5–12, 2020.
View at: Publisher Site | Google Scholar
B. Han, W. Z. Chen, Y. C. Li, J. Chen, and Z. Q. Zeng, “Sleep and hypertension,” Sleep and Breathing, vol. 24, no. 1, pp. 351–356, 2020.
View at: Publisher Site | Google Scholar
L. Wang, Y. Hu, X. Wang, S. Yang, W. Chen, and Z. Zeng, “The association between sleep duration and hypertension: a meta and study sequential analysis,” Journal of Human Hypertension, vol. 35, no. 7, pp. 621–626, 2021.
View at: Publisher Site | Google Scholar
W. J. Li, J. Tian, and L. P. Zhang, “Epidemiological characteristics of hypertension in Mongolian population,” Latest Med Inform Abstr World, vol. 19, no. 77, pp. 37-38, 2019.
View at: Google Scholar
L. Xiu, “A study on the changes of Mongolian culinary culture with the dissemination of agricultural knowledge to the northern part of China,” J Inner Mongolia Univ (Philosophy and Social Sciences), vol. 52, no. 04, pp. 10–17, 2020.
View at: Google Scholar
L. Chen, Y. Zong, T. Wei et al., “Prevalence, awareness, medication, control, and risk factors associated with hypertension in Yi ethnic group aged 50 years and over in rural China: the Yunnan minority eye study,” BMC Public Health, vol. 15, no. 1, p. 383, 2015.
View at: Publisher Site | Google Scholar
J. Zhang, S. Wan, F. Dong et al., “Secular trends of the impact of overweight and obesity on hypertension in Yi people: Yi migrant study,” International Journal of Hypertension, vol. 2020, Article ID 5368357, 9 pages, 2020.
View at: Publisher Site | Google Scholar
Z. Wang, Z. Chen, L. Zhang et al., “Status of hypertension in China: results from the China hypertension survey, 2012-2015,” Circulation, vol. 137, no. 22, pp. 2344–2356, 2018.
View at: Publisher Site | Google Scholar
W. K. Bosu and D. K. Bosu, “Prevalence, awareness and control of hypertension in Ghana: a systematic review and meta-analysis,” PLoS One, vol. 16, no. 3, Article ID e0248137, 2021.
View at: Publisher Site | Google Scholar
G. Shan, D. Wei, C. Wang et al., “Trends of overweight and obesity in Yi people between 1996 and 2007: an Yi migrant study,” Biomedical and Environmental Sciences, vol. 24, no. 5, pp. 467–474, 2011.
View at: Publisher Site | Google Scholar
M. Li and Z. Shi, “Dietary pattern during 1991-2011 and its association with cardio metabolic risks in Chinese adults: the China health and nutrition survey,” Nutrients, vol. 9, no. 11, p. 1218, 2017.
View at: Publisher Site | Google Scholar
S. Arya, A. H. Kaji, and M. A. Boermeester, “PRISMA reporting guidelines for meta-analyses and systematic reviews,” JAMA Surgery, vol. 156, no. 8, pp. 789-790, 2021.
View at: Publisher Site | Google Scholar
L. Sun and Y. Feng, “Can results of meta-analysis with high heterogeneity provide any predictive values?” European Heart Journal, vol. 40, no. 38, p. 3205, 2019.
View at: Publisher Site | Google Scholar
A. C. Alba, P. E. Alexander, J. Chang, J. MacIsaac, S. DeFry, and G. H. Guyatt, “High statistical heterogeneity is more frequent in meta-analysis of continuous than binary outcomes,” Journal of Clinical Epidemiology, vol. 70, pp. 129–135, 2016.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Yanan Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

617

Downloads

515

Citations